Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11078208 HIV inhibitor compounds

Patent 11078208 was granted and assigned to Gilead Sciences on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110782080

Patent Inventor Names

Elbert Chin0

Ashley Anne Katana0

Darryl Kato0

Elizabeth M. Bacon0

Jeromy J. Cottell0

John O. Link0

Nathan Shapiro0

Teresa Alejandra Trejo Martin0

...

Date of Patent

August 3, 2021

Patent Application Number

202003020

Date Filed

March 2, 2020

Patent Citations Received

‌

US Patent 11944611 Capsid inhibitors for the treatment of HIV

‌

US Patent 12077537 Capsid inhibitors for the treatment of HIV

‌

US Patent 12084455 HIV inhibitor compounds

‌

US Patent 11680064 Capsid inhibitors for the treatment of HIV

‌

US Patent 11760746 Methods and intermediates for preparing therapeutic compounds

‌

US Patent 11787825 Therapeutic compounds for HIV virus infection

‌

US Patent 12122765 Methods and intermediates for preparing therapeutic compounds

‌

US Patent 12084467 Therapeutic compounds for HIV virus infection

...

Patent abstract

The invention provides a compound of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11078208 HIV inhibitor compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API